Melphalan neurotoxicity
WebHigh-dose intravenous melphalan followed by peripheral blood stem cell transplant (PBSCT) appears to be the most promising therapy, but treatment mortality can be high. … Web20 mei 2012 · Methods to accurately detect minor changes in disease burden following a low dose of melphalan (LDM) as a marker of melphalan sensitivity are needed to …
Melphalan neurotoxicity
Did you know?
Web17 feb. 2024 · (1) Background: High-dose chemotherapy (HDCT) before autologous stem cell transplantation (ASCT) in acute myeloid leukemia (AML) patients predominantly combines busulfan with cyclophosphamide or melphalan. Treosulfan compares favorably regarding lower inter-individual bioavailability and neurotoxicity, but so far, had not … WebMelphalan was considered by previous IARC Working Groups in 1974 and 1987 (IARC, 1975, 1987a). Since that time, new data have become available, these have been incorporated into the Monograph, and taken …
Web13 mrt. 2024 · High dose melphalan is commonly used as a conditioning regimen for autologous stem cell transplantation in multiple myeloma. There are reports of adverse … WebOur findings suggest that bortezomib plus melphalan–prednisone is a valuable front-line treatment for patients with myeloma who are 65 years of age or older and cannot receive more aggressive ...
WebConclusion: The timing of renal injury strongly suggests melphalan as the causative agent. Ongoing tubular injury may be a prerequisite for renal injury by melphalan as evidenced by the active urinary sediment. Development of ARI adversely affected the … Web20 nov. 2009 · Melphalan and Dexamethasone Plus Bortezomib Induces Hematologic and Organ Responses in AL-Amyloidosis with Tolerable Neurotoxicity. ... and short survival. Standard therapy for patients (pts) not eligible for autologous stem cell transplant (ASCT) is melphalan (Mel; M) + dexamethasone (Dex; D). With non-ASCT therapy, the median ...
Web11 jun. 1998 · Neurotoxicity of isolated limb perfusion with tumor necrosis factor J Neurol Sci. 1998 Jun 11;158(1):1-4. doi: 10.1016/s0022-510x(98)00098-7. Authors V E Drory 1 , D Lev, G B Groozman, M Gutmann, J M Klausner. Affiliation 1 Department of ... Melphalan / therapeutic use
Web5 nov. 2024 · Melphalan treatment induces cell death and apoptosis in hiPSC-CMs. To investigate the cardiotoxicity of melphalan, we generated enriched hiPSC-CMs (Fig. S1) and treated them with melphalan at 4 doses ranging from 0 to 20 μM; the highest dose was slightly above the C max of melphalan (15.4 μM) []. hiPSC-CMs exposed to 20 μM … fix thermocouple ge hot water heaterWeb14 jan. 2024 · A 63-year-old man developed encephalopathy and neurotoxicity during treatment with melphalan [route and duration of treatment to reaction onset not stated] … canning headspace toolWebNeurotoxicity is the damage done to your nervous system when the brain is exposed to something toxic. Toxins can be natural (like from plants or vegetables) or artificial (like medications or chemicals). This toxin changes how the nervous system works, which leads to damage. Both chemotherapy and radiation can be neurotoxic. canning heat rings lids ovenWeb13 feb. 2024 · As contributing factors, brain tumour and tramadol treatment increased the risk of thiotepa-related neurotoxicity by 2 to 6 times respectively. The incidence of … fix thermostatWeb13 mrt. 2024 · A case report: high dose melphalan as a conditioning regimen for multiple myeloma induces sinus arrest eCollection 2024. Authors Liang-Liang Ma # 1 , Ying Liu # 2 , Si-Xun Jia 3 , Hai-Chen Lv 2 , Mei-Yun Fang 3 , Yun-Long Xia 2 Affiliations 1 1Department of Hematology, the First Affiliated Hospital of Dalian Medical University, Dalian, China. canning headspaceWebHigh-dose melphalan has been given intravenously in some malignancies: doses of 100–240 mg/m 2 have been used for neuroblastoma, and … fix the road gameWeb20 nov. 2009 · Melphalan and Dexamethasone Plus Bortezomib Induces Hematologic and Organ Responses in AL-Amyloidosis with Tolerable Neurotoxicity. November 2009 Blood 114(22):746-746 canning health centre